Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Compass Therapeutics, Inc. (CMPX) had Normalized Pre-Tax Income of $-49.38M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.85M |
|
$-49.38M |
|
-- |
|
$0.85M |
|
$57.48M |
|
$-56.62M |
|
$7.25M |
|
$-49.38M |
|
|
Normalized Pre-Tax Income |
$-49.38M |
$-49.38M |
|
$-49.38M |
|
$-49.38M |
|
$-49.38M |
|
$-56.62M |
|
$-56.52M |
|
137.38M |
|
137.38M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$132.75M |
|
$0.35M |
|
$7.65M |
|
$140.40M |
|
$8.87M |
|
-- |
|
$6.30M |
|
$15.17M |
|
$125.23M |
|
$125.23M |
|
$125.23M |
|
137.82M |
|
| Cash Flow Statement Financials | |
$-44.85M |
|
$46.77M |
|
$17.34M |
|
$24.23M |
|
$43.48M |
|
$19.25M |
|
$8.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-6661.77% |
|
-6661.77% |
|
-6649.76% |
|
-5808.82% |
|
-5808.82% |
|
$-44.90M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-39.43% |
|
-39.43% |
|
-35.17% |
|
-39.43% |
|
$0.91 |
|
$-0.33 |
|
$-0.33 |
|